Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$TWSI medical supply contract in China (ask .25)
TWSI begins selling their medical products in China
http://www.otcmarkets.com/stock/TWSI/news
just reported revenues up in 2014 to $5.5 million, expected to become profitable in 2015.
Ask .25 now, which is breakout on the chart as you can see below...dont miss the run!
Texas-Based $STWS Brings Water Revolution To Dry State
By James Burgess
The definitive answer to Texas’ drought, concerns about future supplies of potable water, and oil industry fears of fracking drying up is next generation technology that hits out at the water dilemma on three fronts simultaneously.
Developed in the Netherlands by Salttech, the DyVaR Zero Liquid Discharge (ZLD) water processing technology was licensed in July 2014 by Texas-based STW Resources Holding Corp. (OTCQB: STWS) in the giant oil and gas venue of the Permian Basin. Now the proven next generation technology is moving across the state to provide local citizens and oil producers alike with more water than they ever imagined.
For the dry state of Texas, this is nothing short of revolutionary. As NASA predicts a decades-long ‘mega drought’ later this century, and as the state is already in an unprecedented drought situation, the urgency of this revolution is felt far and wide—particularly in the oil and gas industry, where fracking is dependent on huge supplies of water.
Not only does Texas have the massive Permian Basin and the Eagle Ford oil and gas shale reserves, but it also has the Gulf of Mexico and its endless billions of gallons of seawater that are now economically treatable thanks to the STW Salttech water processing technology.
Onshore, STW Resources is drilling deep under the Texan surface to access new sources of brackish and slightly salty waters and then using its Proprietary Hybrid Reverse Osmosis Technology and its exclusively licensed Salttech system to process these new resources into potable water and supplies for the industrial sector, municipal sector and the oil and gas industry.
Offshore, its plan is to tap into the Gulf of Mexico, desalinating ocean water and turning it into potable water.
The Salttech systems can be manufactured to process as many gallons of water per day as is needed, according to STW Resources, which has the exclusive license for this technology not only in the US, but also options for use in Canada, the Caribbean, Mexico and Central America.
Green All The Way: Economical And Environmentally Friendly
Not only is STW unlocking never-before accessed sources of water deep underground, but its water processing technique is economically feasible.
Economics has always been the bane of desalination, and this has kept it from being undertaken in a more aggressive and commercial way.
Until now, the price of desalinated produced water projects in the oil and gas industry has hovered around $4.50-$8 a barrel, but STW’s project comes in at around $1.50-$2.50 per barrel, which makes it competitive with drilling for and transporting fresh water.
In the ocean desalination business, the key to the economics is the fresh water recovery percentage and the environmental aspects to disposing of the salty concentrated reject fluids.
Before the rise of Salttech, conventional desalination technologies could only recover about 35%-45% of fresh water from a gallon of seawater. STW’s Salttech technology recovers approximately 97% of the fresh water at an economical cost with no potential environmental disposal problems associated with the concentrated salty reject.
At the same time, the new technology uses no chemicals or filtration, rendering it quite possibly the ‘greenest’ water processing technology in operation today.
Adding to the environmental lure is the fact that STW’s Salttech Technology can be operated entirely on solar and/or wind power energy.
The Water Revolution: Mentone and Beyond
Last July saw the first Salttech system operation in the United States launched in Mentone, Texas, in the Permian Basin. The Salttech desalination system is now providing the residents of Mentone with more drinking water than they could have ever hoped for.
But Mentone is just the beginning. STW has even bigger plans for other Permian Basin projects.
In the Capitan Reef Aquifer, on property owned by the city of Fort Stockton, Texas, STW is now drilling its first production well and planning to drill several additional wells into this and other brackish aquifers about 2,000-4,500 feet under the surface The goal is to start selling water in the 2nd-3rd quarters of this year.
The Capitan Reef Project is a highly ambitious one with a price tag of $42.5+ million. This project is tapping into possibly 14 million acre feet of water—or about 5.6 trillion gallons, with a potential production rate of 100+ million gallons per day. In the first phase, the project will drill up to 11 production wells to pump up to 10+ million gallons per day. The plan is to provide potable water to thousands of west Texans in several municipalities in west Texas that are still in drought status.
Beyond this, the coming years foresee giant leaps forward in the water revolution.
Among other plans over the next couple of years, one of STW’s ports of call will be the Gulf Coast of Texas; once ocean water is being processed on the Texas coast, businesses will flood in.
“With the shortage of fresh water worldwide, our technology can help in many areas to relieve the shortages. We can also assist in any ocean desalination reverse operations to exclude the need to dispose of the concentrated brine reject into local waterways and oceans thus preventing any possible detrimental effects to the highly sensitive balance of the ecosystem. The STW Salttech DyVaR system is a major technological breakthrough since we can now economically process high chloride water into potable water and not have any detrimental effects on our environment,” Stanley Weiner, CEO of STW Resources, said in a January 2015 press release.
What It Means For The Oil Industry
Could this be the reason for Saudi Arabia's stance on oil supplies?
There's an incredible energy development we've been keeping track of for you over the past year... It's the reason Saudi Arabia is acting in desperation... depressing oil prices... and even risking internal unrest. Their (and OPEC’s) very survival is being threatened.
And we believe we’ve put together an incredible video revealing how it works.
For the oil industry, this is a breakthrough technology that could save untold sums of money by reclaiming the massive volumes of precious water used in drilling and fracking and also processing produced water that accompanies oil and gas production.
Water-starved Texas is a highly competitive playing field and the competition between oil companies and other heavy users of water is intense. The shale boom and the hydraulic fracturing revolution have exponentially raised the stakes in this competition as demand for fresh water has soared, alongside an influx of thousands of new residents to Texas.
Producers are surrounded in a pincer movement, both by critics of how much water they use and by internal pressure to ensure enough supplies of water to keep drilling and fracking.
Three-quarters of the some 40,000 wells drilled since 2011 have been in areas where water is scarce, according to a 2014 report by the Ceres investor network. Of those, 55% were drilled in areas of drought.
When you add to this the fact that fracking those thousands of wells required 97 billion gallons of water, a picture emerges not only of general water scarcity, but of an end to the shale boom due to lack of water.
As such, it is only appropriate that water revolution begins exactly where the shale revolution emerged.
Innovative Integration
As an energy and water services company, STW Resources is rather unique. It recognized a great need to enhance and expand its operations, and set out to add the most precious element of all to its portfolio—water.
As an integrated provider of water management and oilfield services, the company’s level of integration resembles that of the supermajors. The company provides a vast range of services through three subsidiaries, STW Water, STW Energy Services and STW Pipeline Maintenance and Construction Services.
“Water is why we founded the company,” according to STW Resources CEO Stanley Weiner.
According to Weiner, STW’s initial goal was to target frack water in the oil business, but his team soon realized the endless possibilities of actually accessing and processing water that had never before been considered for human consumption. As such, “We are actually increasing the supply of fresh water into our ecosystem,” he said.
Growth has been impressive. In October 2013, STW had only 8 employees; now it has 150. In 2014, the company booked $20 million in revenues.
STW’s pipeline subsidiary, which both maintains and builds new pipelines, is poised to see growth double this year, as Texas’ hundreds of thousands of miles of aging existing pipelines have many anomalies that need repair, and the state is in constant need of new pipeline connects.
On the STW Energy side of the equation, the company is sitting pretty because it avoids aspects that it considers ‘too upstream’ and vulnerable to today’s low oil prices. Here again, the company is poised to see growth in its oil services segment.
And when it comes to water, there is no turning back the tide now. Over the next six months, STW plans to initiate several projects, including a major desalination project for a large NYSE-listed oil and gas company.
The deal is a major breakthrough: After years of experimenting, it will be the first time STW turns a profit from selling processed water to the oil industry using hybrid reverse osmosis technology and its Salttech desalination technology.
For the oil and gas companies, it is also a breakthrough—one that will ensure it a hearty, long-term supply of water and to help preserve precious fresh water resources.
The next six months are key for potential investors because this is when STW will achieve full commercialization: Supply, access to market, customer agreements and permitting in place.
Even more growth is in store for this company which highly prioritizes technological innovation and integration. The company is also exploring a creative purification technology that turns toilet water into tap water. STW will be conducting a pilot on this technology in a major Texas city in the coming months.
For Texas, the water revolution has begun—simultaneously for citizens, local governments and the oil industry. And what happens in Texas is likely to spread to other dry US states, and beyond.
By James Burgess of Oilprice.com
Texas-Based $STWS Brings Water Revolution To Dry State
By James Burgess
The definitive answer to Texas’ drought, concerns about future supplies of potable water, and oil industry fears of fracking drying up is next generation technology that hits out at the water dilemma on three fronts simultaneously.
Developed in the Netherlands by Salttech, the DyVaR Zero Liquid Discharge (ZLD) water processing technology was licensed in July 2014 by Texas-based STW Resources Holding Corp. (OTCQB: STWS) in the giant oil and gas venue of the Permian Basin. Now the proven next generation technology is moving across the state to provide local citizens and oil producers alike with more water than they ever imagined.
For the dry state of Texas, this is nothing short of revolutionary. As NASA predicts a decades-long ‘mega drought’ later this century, and as the state is already in an unprecedented drought situation, the urgency of this revolution is felt far and wide—particularly in the oil and gas industry, where fracking is dependent on huge supplies of water.
Not only does Texas have the massive Permian Basin and the Eagle Ford oil and gas shale reserves, but it also has the Gulf of Mexico and its endless billions of gallons of seawater that are now economically treatable thanks to the STW Salttech water processing technology.
Onshore, STW Resources is drilling deep under the Texan surface to access new sources of brackish and slightly salty waters and then using its Proprietary Hybrid Reverse Osmosis Technology and its exclusively licensed Salttech system to process these new resources into potable water and supplies for the industrial sector, municipal sector and the oil and gas industry.
Offshore, its plan is to tap into the Gulf of Mexico, desalinating ocean water and turning it into potable water.
The Salttech systems can be manufactured to process as many gallons of water per day as is needed, according to STW Resources, which has the exclusive license for this technology not only in the US, but also options for use in Canada, the Caribbean, Mexico and Central America.
Green All The Way: Economical And Environmentally Friendly
Not only is STW unlocking never-before accessed sources of water deep underground, but its water processing technique is economically feasible.
Economics has always been the bane of desalination, and this has kept it from being undertaken in a more aggressive and commercial way.
Until now, the price of desalinated produced water projects in the oil and gas industry has hovered around $4.50-$8 a barrel, but STW’s project comes in at around $1.50-$2.50 per barrel, which makes it competitive with drilling for and transporting fresh water.
In the ocean desalination business, the key to the economics is the fresh water recovery percentage and the environmental aspects to disposing of the salty concentrated reject fluids.
Before the rise of Salttech, conventional desalination technologies could only recover about 35%-45% of fresh water from a gallon of seawater. STW’s Salttech technology recovers approximately 97% of the fresh water at an economical cost with no potential environmental disposal problems associated with the concentrated salty reject.
At the same time, the new technology uses no chemicals or filtration, rendering it quite possibly the ‘greenest’ water processing technology in operation today.
Adding to the environmental lure is the fact that STW’s Salttech Technology can be operated entirely on solar and/or wind power energy.
The Water Revolution: Mentone and Beyond
Last July saw the first Salttech system operation in the United States launched in Mentone, Texas, in the Permian Basin. The Salttech desalination system is now providing the residents of Mentone with more drinking water than they could have ever hoped for.
But Mentone is just the beginning. STW has even bigger plans for other Permian Basin projects.
In the Capitan Reef Aquifer, on property owned by the city of Fort Stockton, Texas, STW is now drilling its first production well and planning to drill several additional wells into this and other brackish aquifers about 2,000-4,500 feet under the surface The goal is to start selling water in the 2nd-3rd quarters of this year.
The Capitan Reef Project is a highly ambitious one with a price tag of $42.5+ million. This project is tapping into possibly 14 million acre feet of water—or about 5.6 trillion gallons, with a potential production rate of 100+ million gallons per day. In the first phase, the project will drill up to 11 production wells to pump up to 10+ million gallons per day. The plan is to provide potable water to thousands of west Texans in several municipalities in west Texas that are still in drought status.
Beyond this, the coming years foresee giant leaps forward in the water revolution.
Among other plans over the next couple of years, one of STW’s ports of call will be the Gulf Coast of Texas; once ocean water is being processed on the Texas coast, businesses will flood in.
“With the shortage of fresh water worldwide, our technology can help in many areas to relieve the shortages. We can also assist in any ocean desalination reverse operations to exclude the need to dispose of the concentrated brine reject into local waterways and oceans thus preventing any possible detrimental effects to the highly sensitive balance of the ecosystem. The STW Salttech DyVaR system is a major technological breakthrough since we can now economically process high chloride water into potable water and not have any detrimental effects on our environment,” Stanley Weiner, CEO of STW Resources, said in a January 2015 press release.
What It Means For The Oil Industry
Could this be the reason for Saudi Arabia's stance on oil supplies?
There's an incredible energy development we've been keeping track of for you over the past year... It's the reason Saudi Arabia is acting in desperation... depressing oil prices... and even risking internal unrest. Their (and OPEC’s) very survival is being threatened.
And we believe we’ve put together an incredible video revealing how it works.
For the oil industry, this is a breakthrough technology that could save untold sums of money by reclaiming the massive volumes of precious water used in drilling and fracking and also processing produced water that accompanies oil and gas production.
Water-starved Texas is a highly competitive playing field and the competition between oil companies and other heavy users of water is intense. The shale boom and the hydraulic fracturing revolution have exponentially raised the stakes in this competition as demand for fresh water has soared, alongside an influx of thousands of new residents to Texas.
Producers are surrounded in a pincer movement, both by critics of how much water they use and by internal pressure to ensure enough supplies of water to keep drilling and fracking.
Three-quarters of the some 40,000 wells drilled since 2011 have been in areas where water is scarce, according to a 2014 report by the Ceres investor network. Of those, 55% were drilled in areas of drought.
When you add to this the fact that fracking those thousands of wells required 97 billion gallons of water, a picture emerges not only of general water scarcity, but of an end to the shale boom due to lack of water.
As such, it is only appropriate that water revolution begins exactly where the shale revolution emerged.
Innovative Integration
As an energy and water services company, STW Resources is rather unique. It recognized a great need to enhance and expand its operations, and set out to add the most precious element of all to its portfolio—water.
As an integrated provider of water management and oilfield services, the company’s level of integration resembles that of the supermajors. The company provides a vast range of services through three subsidiaries, STW Water, STW Energy Services and STW Pipeline Maintenance and Construction Services.
“Water is why we founded the company,” according to STW Resources CEO Stanley Weiner.
According to Weiner, STW’s initial goal was to target frack water in the oil business, but his team soon realized the endless possibilities of actually accessing and processing water that had never before been considered for human consumption. As such, “We are actually increasing the supply of fresh water into our ecosystem,” he said.
Growth has been impressive. In October 2013, STW had only 8 employees; now it has 150. In 2014, the company booked $20 million in revenues.
STW’s pipeline subsidiary, which both maintains and builds new pipelines, is poised to see growth double this year, as Texas’ hundreds of thousands of miles of aging existing pipelines have many anomalies that need repair, and the state is in constant need of new pipeline connects.
On the STW Energy side of the equation, the company is sitting pretty because it avoids aspects that it considers ‘too upstream’ and vulnerable to today’s low oil prices. Here again, the company is poised to see growth in its oil services segment.
And when it comes to water, there is no turning back the tide now. Over the next six months, STW plans to initiate several projects, including a major desalination project for a large NYSE-listed oil and gas company.
The deal is a major breakthrough: After years of experimenting, it will be the first time STW turns a profit from selling processed water to the oil industry using hybrid reverse osmosis technology and its Salttech desalination technology.
For the oil and gas companies, it is also a breakthrough—one that will ensure it a hearty, long-term supply of water and to help preserve precious fresh water resources.
The next six months are key for potential investors because this is when STW will achieve full commercialization: Supply, access to market, customer agreements and permitting in place.
Even more growth is in store for this company which highly prioritizes technological innovation and integration. The company is also exploring a creative purification technology that turns toilet water into tap water. STW will be conducting a pilot on this technology in a major Texas city in the coming months.
For Texas, the water revolution has begun—simultaneously for citizens, local governments and the oil industry. And what happens in Texas is likely to spread to other dry US states, and beyond.
By James Burgess of Oilprice.com
It's nice to see some movement today, getting excited again!
Yeah, I have a position in STWS, great company. Definitely a longer hold than most otc stocks, this is sure to run in the summer!
Conference today! Last chance to get in!!
SCRC trying to climb back to .09... we'll be seeing double digits next week!
SCRC Stock Could be Positioned for Snap-Back Rally Next Week
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
SCRC Stock Could be Positioned for Snap-Back Rally Next Week
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
SCRC Stock Could be Positioned for Snap-Back Rally Next Week
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
Bid
0.082
Ask
0.083
B/A Size
10000x20000
SCRC Stock Could be Positioned for Snap-Back Rally Next Week
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
There was a post market buy at 4:11pm et that brought this back up to .105. You guys without L2 will see in the morning. GLTA!!
Bidding .0675.... ouch
Aaaand my order was just filled
What happened here? I feel like since I loaded up, the runs stopped...
I have another order at .07, so it's a win/win whether or not this keeps dropping or not!
Dropping in the .07's now
who's 'CORE'?
who do you think is dumping so much?
Yup! Me too!! Just got in at the best price all year!! :D
NEWSSSS!!
HemCon Medical Technologies Launches into Chinese Market
PORTLAND, Ore., April 7, 2015 /PRNewswire/ -- TriStar Wellness Solutions, Inc. (TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, through its subsidiary, HemCon Medical Technologies, Inc has received regulatory approval from the China Food and Drug Administration (CFDA) to market and sell products into China. HemCon has commercially entered the market this month by accepting an order through a distributor on the mainland. HemCon's launch into the Chinese market will include its full portfolio of wound care solutions which are protected by patents both in China and throughout the world. Currently the wound care market in China is estimated at $1.2 billion.
Photo - http://photos.prnewswire.com/prnh/20150406/196695
Photo - http://photos.prnewswire.com/prnh/20150406/196696
HemCon has prior experience in the pan-Asian market having successfully established a wound care product line in Japan with their partner ZERIA Pharmaceutical.
Michael Wax, President and CEO said, "With our initial Chinese order in hand, combined with the Chinese government's approval for import of our dressings, we are looking ahead to building a robust business in a rapidly growing market. We have expectations to participate in the fast growing pan-Asian health care industry and specifically the increasing demand for wound care in China."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Stephanie Wiegman
Tel: (503) 245-0459
Email
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hemcon-medical-technologies-launches-into-chinese-market-300061723.html
Yeah I agree, and in addition this is a great price to get in at! Waiting for some funds to clear in order to pick up more. These sellers are idiots, but it's their loss!
Nice! I'm in both of those! Great plays.
Very bullish chart. Only 1k shares left to bring this back to .85
MBLY mentioned in car tech article on Wall Street Newscast
http://wallstreetnewscast.com/news/2015/03/icor-2476.html
ICOR Expands their Driver Alertness Car Technology to Asia
By: staff reporter, Melissa Diaz
Last Updated: March 25, 2015 8:45 AM EST
(NEW YORK)--InterCore, Inc. (OTC:ICOR) deal to install their driver alertness detection system in Vietnam based automaker SAMCO vehicles now positions ICOR as player in the car technology sector.
ICOR recently announced that its Driver Alertness Detection System (DADS) will be deployed in a trial installation with PT Trans Continent, Indonesia.
PT Trans Continent is the leading Supply Chain operator for Sodium Cyanide used in the Gold Mining Industries in the Republic of Indonesia. DADS will be installed for a three-month trial in PT Trans Continent vehicles that are part of the more than 2,000 trucks in this segment of the Indonesian market.
"Fatigue is a major killer in the trucking industry in Indonesia. Being able to accurately monitor drivers in real time for their safety, and the safety of the goods they haul, is on the top of our agenda," said George Chin, Technical Advisor and Consultant, PT Trans Continent.
This new contract comes on the heels that ICOR Driver Alertness Detection System (DADS(TM)) would also be deployed in a trial installation by SAMCO (Saigon Transportation Mechanical Corporation), Vietnam.
SAMCO is a State-owned enterprise known for its manufacturing and mechanical engineering capabilities, with annual sales in excess of US$500 million. SAMCO is a major manufacturer of various and specialized vehicles, including passenger cars and busses, as well as ships.
The DADS trial, expected to begin by April 2015, marks the first such trial in Asia. The DADS service is currently in a pilot program in more than 5,700 trucks operating throughout Canada and the US.
Car technology stocks has been building big interest as tech firms fight for control of driver dashboards. Grabbing attention has been the chatter of Apple's CarPlay, and Google's Android Auto in attempt to become the new operating systems of sorts for both consumer and commercial vehicles.
To get an idea how large the interest is in new car technology one can only look at Mobileye (MBLY), which has positioned itself at the forefront of long-term autonomous vehicle technology growth prospects.
The issue with 'drowsy drivers' causing crashes on the roads, and issues with higher insurance payouts, puts ICOR in forefront in battle to prevent crashes from sleepy drivers, such as seen last year in the Walmart crash with comedian Tracy Morgan. Add in prospects larger car makers are looking to add these tech features into their new models, and idea of ICOR potentially scoring deals with larger car makers to incorporate their driver alertness detection system, like Ford, BMW, or Toyota, and the upside potential for ICOR could be great.
Intercore, Inc. is currently traded on the OTCQB exchange, and closed Tuesday at a price of $4.08 per share.
http://www.otcmarkets.com/stock/icor/quote
About InterCore, Inc.
InterCore, Inc. (ICOR) is a public company focused on the commercialization and deployment of the DADS(TM) service and related products through its subsidiary, InterCore Research Canada, Inc. Designed around proprietary alertness detection technologies, DADS(TM) helps alert operators to their work activity capability based on real-time monitoring of their state of alertness. www.intercoreinc.com.
$ICOR Expands their Driver Alertness Car Technology to Asia
By: staff reporter, Melissa Diaz
Last Updated: March 25, 2015 8:45 AM EST
http://wallstreetnewscast.com/news/2015/03/icor-2476.html
(NEW YORK)--InterCore, Inc. (OTC:ICOR) deal to install their driver alertness detection system in Vietnam based automaker SAMCO vehicles now positions ICOR as player in the car technology sector.
ICOR recently announced that its Driver Alertness Detection System (DADS) will be deployed in a trial installation with PT Trans Continent, Indonesia.
PT Trans Continent is the leading Supply Chain operator for Sodium Cyanide used in the Gold Mining Industries in the Republic of Indonesia. DADS will be installed for a three-month trial in PT Trans Continent vehicles that are part of the more than 2,000 trucks in this segment of the Indonesian market.
"Fatigue is a major killer in the trucking industry in Indonesia. Being able to accurately monitor drivers in real time for their safety, and the safety of the goods they haul, is on the top of our agenda," said George Chin, Technical Advisor and Consultant, PT Trans Continent.
This new contract comes on the heels that ICOR Driver Alertness Detection System (DADS(TM)) would also be deployed in a trial installation by SAMCO (Saigon Transportation Mechanical Corporation), Vietnam.
SAMCO is a State-owned enterprise known for its manufacturing and mechanical engineering capabilities, with annual sales in excess of US$500 million. SAMCO is a major manufacturer of various and specialized vehicles, including passenger cars and busses, as well as ships.
The DADS trial, expected to begin by April 2015, marks the first such trial in Asia. The DADS service is currently in a pilot program in more than 5,700 trucks operating throughout Canada and the US.
Car technology stocks has been building big interest as tech firms fight for control of driver dashboards. Grabbing attention has been the chatter of Apple's CarPlay, and Google's Android Auto in attempt to become the new operating systems of sorts for both consumer and commercial vehicles.
To get an idea how large the interest is in new car technology one can only look at Mobileye (MBLY), which has positioned itself at the forefront of long-term autonomous vehicle technology growth prospects.
The issue with 'drowsy drivers' causing crashes on the roads, and issues with higher insurance payouts, puts ICOR in forefront in battle to prevent crashes from sleepy drivers, such as seen last year in the Walmart crash with comedian Tracy Morgan. Add in prospects larger car makers are looking to add these tech features into their new models, and idea of ICOR potentially scoring deals with larger car makers to incorporate their driver alertness detection system, like Ford, BMW, or Toyota, and the upside potential for ICOR could be great.
Intercore, Inc. is currently traded on the OTCQB exchange, and closed Tuesday at a price of $4.08 per share.
http://www.otcmarkets.com/stock/icor/quote
About InterCore, Inc.
InterCore, Inc. (ICOR) is a public company focused on the commercialization and deployment of the DADS(TM) service and related products through its subsidiary, InterCore Research Canada, Inc. Designed around proprietary alertness detection technologies, DADS(TM) helps alert operators to their work activity capability based on real-time monitoring of their state of alertness. www.intercoreinc.com.
$ICOR Expands their Driver Alertness Car Technology to Asia
By: staff reporter, Melissa Diaz
Last Updated: March 25, 2015 8:45 AM EST
http://wallstreetnewscast.com/news/2015/03/icor-2476.html
(NEW YORK)--InterCore, Inc. (OTC:ICOR) deal to install their driver alertness detection system in Vietnam based automaker SAMCO vehicles now positions ICOR as player in the car technology sector.
ICOR recently announced that its Driver Alertness Detection System (DADS) will be deployed in a trial installation with PT Trans Continent, Indonesia.
PT Trans Continent is the leading Supply Chain operator for Sodium Cyanide used in the Gold Mining Industries in the Republic of Indonesia. DADS will be installed for a three-month trial in PT Trans Continent vehicles that are part of the more than 2,000 trucks in this segment of the Indonesian market.
"Fatigue is a major killer in the trucking industry in Indonesia. Being able to accurately monitor drivers in real time for their safety, and the safety of the goods they haul, is on the top of our agenda," said George Chin, Technical Advisor and Consultant, PT Trans Continent.
This new contract comes on the heels that ICOR Driver Alertness Detection System (DADS(TM)) would also be deployed in a trial installation by SAMCO (Saigon Transportation Mechanical Corporation), Vietnam.
SAMCO is a State-owned enterprise known for its manufacturing and mechanical engineering capabilities, with annual sales in excess of US$500 million. SAMCO is a major manufacturer of various and specialized vehicles, including passenger cars and busses, as well as ships.
The DADS trial, expected to begin by April 2015, marks the first such trial in Asia. The DADS service is currently in a pilot program in more than 5,700 trucks operating throughout Canada and the US.
Car technology stocks has been building big interest as tech firms fight for control of driver dashboards. Grabbing attention has been the chatter of Apple's CarPlay, and Google's Android Auto in attempt to become the new operating systems of sorts for both consumer and commercial vehicles.
To get an idea how large the interest is in new car technology one can only look at Mobileye (MBLY), which has positioned itself at the forefront of long-term autonomous vehicle technology growth prospects.
The issue with 'drowsy drivers' causing crashes on the roads, and issues with higher insurance payouts, puts ICOR in forefront in battle to prevent crashes from sleepy drivers, such as seen last year in the Walmart crash with comedian Tracy Morgan. Add in prospects larger car makers are looking to add these tech features into their new models, and idea of ICOR potentially scoring deals with larger car makers to incorporate their driver alertness detection system, like Ford, BMW, or Toyota, and the upside potential for ICOR could be great.
Intercore, Inc. is currently traded on the OTCQB exchange, and closed Tuesday at a price of $4.08 per share.
http://www.otcmarkets.com/stock/icor/quote
About InterCore, Inc.
InterCore, Inc. (ICOR) is a public company focused on the commercialization and deployment of the DADS(TM) service and related products through its subsidiary, InterCore Research Canada, Inc. Designed around proprietary alertness detection technologies, DADS(TM) helps alert operators to their work activity capability based on real-time monitoring of their state of alertness. www.intercoreinc.com.
$TWSI Closes New Hospital Contract for their Medical Products
By: staff reporter, John Bodger
Last Updated: March 24, 2015 11:15 AM EST
http://wallstreetnewscast.com/news/2015/03/twsi-2813.html
(NEW YORK)--HemCon Medical Technologies, Inc., a wholly owned subsidiary of TriStar Wellness Solutions, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market.
Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market.
Earnings Watch
For the nine months ended September 30, 2014, TWSI reported revenues rose roughly 70% to $4,435,000, as compared to $2,574,000 for same period in 2013, while our operating loss decreased 35% to $2,993,000, from $4,685,000 in the same nine month period in 2013.
TWSI is expected to report fiscal 2014 financial results within the next week, and for 2015 the Company anticipates sharply higher revenues, and profitability.
When compared to other players within this sector, such as ARTH and UEEC, TWSI provides the most value with a market cap of just $3 million, rapidly growing revenues, and anticipated profitability in 2015.
TWSI currently trades on the Over the Counter OTCQB market, with around 24 million common shares issued and outstanding.
http://www.otcmarkets.com/stock/twsi/quote
About HemCon Medical Technologies, Inc.
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com
$TWSI Closes New Hospital Contract for their Medical Products
By: staff reporter, John Bodger
Last Updated: March 24, 2015 11:15 AM EST
http://wallstreetnewscast.com/news/2015/03/twsi-2813.html
(NEW YORK)--HemCon Medical Technologies, Inc., a wholly owned subsidiary of TriStar Wellness Solutions, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market.
Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market.
Earnings Watch
For the nine months ended September 30, 2014, TWSI reported revenues rose roughly 70% to $4,435,000, as compared to $2,574,000 for same period in 2013, while our operating loss decreased 35% to $2,993,000, from $4,685,000 in the same nine month period in 2013.
TWSI is expected to report fiscal 2014 financial results within the next week, and for 2015 the Company anticipates sharply higher revenues, and profitability.
When compared to other players within this sector, such as ARTH and UEEC, TWSI provides the most value with a market cap of just $3 million, rapidly growing revenues, and anticipated profitability in 2015.
TWSI currently trades on the Over the Counter OTCQB market, with around 24 million common shares issued and outstanding.
http://www.otcmarkets.com/stock/twsi/quote
About HemCon Medical Technologies, Inc.
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com
More $TWSI NEWS!!
HemCon Medical Technologies, Inc. Receives 2015 Best of Portland Award
PR Newswire HemCon Medical Technologies, Inc.
?
PORTLAND, Ore., March 24, 2015 /PRNewswire/ -- HemCon Medical Technologies, Inc ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (TWSI) and a leading developer and marketer of advanced wound care products, today announced it received the 2015 Best of Portland Award in the Bandages & Dressing category by the Portland Award Program.
Logo - http://photos.prnewswire.com/prnh/20150323/183928LOGO
Logo - http://photos.prnewswire.com/prnh/20150323/183927LOGO
Each year, the Portland Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Portland area a great place to live, work and play.
Various sources of information were gathered and analyzed to choose the winners in each category. The 2015 Portland Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Portland Award Program and data provided by third parties.
Michael Wax, CEO of HemCon, said, "We are honored that our community here in Portland has chosen to recognize our company. It is a credit to all the employees here in Portland and our employees in the EU who have worked so diligently to produce superior medical devices."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.
About Portland Award Program
The Portland Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Portland area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.
The Portland Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community's contributions to the U.S. economy
$TWSI NEWS!!
HemCon Medical Technologies, Inc. Receives 2015 Best of Portland Award
PR Newswire HemCon Medical Technologies, Inc.
?
PORTLAND, Ore., March 24, 2015 /PRNewswire/ -- HemCon Medical Technologies, Inc ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (TWSI) and a leading developer and marketer of advanced wound care products, today announced it received the 2015 Best of Portland Award in the Bandages & Dressing category by the Portland Award Program.
Logo - http://photos.prnewswire.com/prnh/20150323/183928LOGO
Logo - http://photos.prnewswire.com/prnh/20150323/183927LOGO
Each year, the Portland Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Portland area a great place to live, work and play.
Various sources of information were gathered and analyzed to choose the winners in each category. The 2015 Portland Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Portland Award Program and data provided by third parties.
Michael Wax, CEO of HemCon, said, "We are honored that our community here in Portland has chosen to recognize our company. It is a credit to all the employees here in Portland and our employees in the EU who have worked so diligently to produce superior medical devices."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.
About Portland Award Program
The Portland Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Portland area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.
The Portland Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community's contributions to the U.S. economy